ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$53,011
-9.9%
1,953,242
+2.0%
0.06%
-11.1%
Q2 2023$58,843
-16.5%
1,914,216
-2.1%
0.07%
-20.9%
Q1 2023$70,479
-28.6%
1,956,125
-21.7%
0.09%
-34.1%
Q4 2022$98,755
-99.9%
2,498,870
+30.1%
0.14%
+21.1%
Q3 2022$77,203,000
+73.8%
1,921,426
+81.9%
0.11%
+81.0%
Q2 2022$44,418,000
+92.4%
1,056,555
+78.3%
0.06%
+117.2%
Q1 2022$23,083,000
+976.6%
592,477
+898.6%
0.03%
+866.7%
Q3 2021$2,144,000
+174.5%
59,330
+231.5%
0.00%
+200.0%
Q1 2021$781,000
-93.7%
17,900
-93.9%
0.00%
-95.0%
Q3 2020$12,389,000294,4810.02%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders